Tuesday, 17 November 2026European Markets

BERGENBIO Stock Went Up By Over 10% So Far Today

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of BERGENBIO (Oslo Børs Benchmark Index_GI: BGBIO.OL) rose by a staggering 10.47% to kr1.90 at 11:23 EST on Wednesday, following the last session's upward trend. Oslo Børs Benchmark Index_GI is dropping 0.47% to kr1,210.96, following the last session's downward trend. This seems, so far, a somewhat negative trend trading session today.

About BERGENBIO

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase II clinical development that focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and COVID-1. The company is also developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase Ib clinical trial. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-3.76.

Volatility

BERGENBIO's last week, last month's, and last quarter's current intraday variation average was a positive 0.84%, a negative 1.00%, and a positive 3.49%.

BERGENBIO's highest amplitude of average volatility was 7.30% (last week), 5.01% (last month), and 3.49% (last quarter).

More news about BERGENBIO (BGBIO.OL).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 17 May 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›